EUCTR2010‐024202‐34‐DE.

Study name	Effect of oxytocin on therapy results of a group based social skill training in adolescents with autism spectrum disorder
Methods	Parallel trial of oxytocin versus placebo
Participants	Inclusion criteria: male participants aged 8‐18 years diagnosis of ASD according to ICD‐10 native German speaker no or stable psychopharmacotherapy consent is provided to participate Exclusion criteria: IQ < 80 female any psychiatric diagnoses any serious medical condition allergic or hypersensitive to oxytocin lesions to the brain Location/setting: Germany Sample size: not known
Interventions	Intervention (oxytocin): 40 IU oxytocin nasal spray (trial registry does not state the frequency) Comparator (placebo): equivalent placebo nasal spray
Outcomes	Primary outcomes: unclear Secondary outcomes: QoL (scale not reported) Timing of outcome assessments: unclear
Starting date	Registered December 2013
Contact information	Contact name: Tanja Schad‐Hansjosten E‐mail: tanja.schad@zi‐mannheim.de
Notes	Source of funding: appears to be a pharmaceutical company (Universitätsmedizin Göttingen, Georg‐August‐Universität, Klinik für Kinder‐ und Jugendpsychiatrie/Psychotherapie) Conflicts of interest: unclear